Bandingkan Harga & Kinerja Kian Santang Muliatama Tbk. (RGAS) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Kian Santang Muliatama Tbk. dan Organon Pharma Indonesia Tbk.: Kian Santang Muliatama Tbk. diperdagangkan di Rp114 (kapitalisasi pasar 163,43 M, volume 24 jam 36,43 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Kian Santang Muliatama Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| RGAS | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 163,43 M | 104,4 M |
Volume | 36,43 jt | — |
Lot | 364,26 rb | — |
Perputaran | 4 M | — |
Harga Rata-rata | 109,89 | — |
Nilai Transaksi | 4 M | — |
Harga Ekuilibrium Indikatif | 114 | — |
Volume Ekuilibrium Indikatif | 5,9 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Kian Santang Muliatama Tbk.
PT Kian Santang Muliatama Tbk (the Entity) was established based on the Notarial Deed of Artisa Khamelia Ramadiyanti, S.H., M.Kn., No. 634, dated November 28, 2018. The Entity started its commercial operations on 2019. The controlling party for the Company is Edy Nurhamid Amin.
Selengkapnya di halaman RGAS →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
